Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | CEO and President, Director | Common Stock | 2.04M | $3.23M | $1.58 | Feb 29, 2024 | Direct |
Akebia Therapeutics, Inc. | CEO and President, Director | Common Stock | 100K | $158K | $1.58 | Feb 29, 2024 | Held By Dorothy Butler GRAT November 2019 |
Akebia Therapeutics, Inc. | CEO and President, Director | Common Stock | 100K | $158K | $1.58 | Feb 29, 2024 | Held By John Butler GRAT November 2019 |
Akebia Therapeutics, Inc. | CEO and President, Director | Common Stock | 59.9K | $94.7K | $1.58 | Feb 29, 2024 | Held by Dorothy Butler 2019 GRAT |
Akebia Therapeutics, Inc. | CEO and President, Director | Common Stock | 59.9K | $94.7K | $1.58 | Feb 29, 2024 | Held by John Butler 2019 GRAT |
Akebia Therapeutics, Inc. | CEO and President, Director | Stock Option (Right to buy) | 905K | Jan 31, 2024 | Direct | ||
Zynerba Pharmaceuticals, Inc. | Director | Common Stock | 0 | $1.33 | Oct 10, 2023 | Direct | |
Zynerba Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | Feb 29, 2024 | 1 | -$73.6K | 4 | Mar 1, 2024 | CEO and President, Director |
AKBA | Akebia Therapeutics, Inc. | Feb 27, 2024 | 1 | -$57.4K | 4 | Feb 29, 2024 | CEO and President, Director |
AKBA | Akebia Therapeutics, Inc. | Jan 31, 2024 | 3 | -$78.1K | 4 | Feb 2, 2024 | CEO and President, Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Oct 10, 2023 | 4 | $0 | 4 | Oct 11, 2023 | Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jun 13, 2023 | 3 | -$40 | 4 | Jun 15, 2023 | Director |
AKBA | Akebia Therapeutics, Inc. | Mar 1, 2023 | 3 | -$80.6K | 4 | Mar 3, 2023 | CEO and President, Director |
AKBA | Akebia Therapeutics, Inc. | Feb 27, 2023 | 1 | -$31.4K | 4 | Mar 1, 2023 | CEO and President, Director |
AKBA | Akebia Therapeutics, Inc. | Jan 31, 2023 | 3 | $0 | 4 | Feb 2, 2023 | CEO and President, Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jun 14, 2022 | 3 | -$54 | 4 | Jun 16, 2022 | Director |
AKBA | Akebia Therapeutics, Inc. | Feb 28, 2022 | 6 | -$171K | 4 | Mar 2, 2022 | CEO and President, Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | Director |
AKBA | Akebia Therapeutics, Inc. | Dec 12, 2018 | 1 | $0 | 4/A | Feb 18, 2022 | CEO and President, Director |